Andrei A. Bunaciu, graduated the Politehnica University of Bucharest in 1979. He received the Ph.D. degree from the Politehnica University of Bucharest, Faculty of Chemistry, Department of Analytical Chemistry in the field of ion-selective membrane electrodes applied in pharmaceutical analysis in 1990. After several years as Senior Researcher in the Institute of Chemical and Pharmaceutical Research and Romanian Intelligence Service, he was also Senior Researcher in Vibrational Spectroscopy Department at SCIENT - Research Center for Instrumental Analysis, Bucharest. Now he is the C.E.O. of AAB_IR research company, www.aab-ir.ro. His research interests concern molecular recognition of pharmaceutical and biological compounds, using infrared spectroscopy techniques. He is the author/co-author of about 92 publications in medical and pharmaceutical analysis, using different analytical techniques. He is the author/co-author of a book VIBRATIONAL SPECTROSCOPY APPLICATIONS IN BIOMEDICAL, PHARMACEUTICAL AND FOOD SCIENCES, A.A. Bunaciu, H.Y. Aboul-Enein and V.D. Hoang, published in 2020 by Elsevier, Inc. and two chapters: VIBRATIONAL SPECTROSCOPY APPLICATIONS IN DRUG-ANALYSIS, A.A. Bunaciu, H.Y. Aboul-Enein, in Encyclopedia of Spectroscopy and Spectrometry, 3rd Edition, Lindon, J.C., Tranter, G.E. and Koppenaal, D.W. (eds.), Oxford; Elsevier, 2017, vol. 4, pp. 575-581, and respectively RECENT APPLICATIONS OF INFRARED SPECTROSCOPY IN BIOMEDICAL ANALYSIS, A.A. Bunaciu, H.Y. Aboul-Enein, in FTIR Spectroscopy: Advances in Research and Applications, edited by Adriana S. Franca and Leandro S. Oliveira, Nova Publishers, NY, USA, 2022, pp. 575-581.

Dr. Octavian Bucur, MD, PhD, is an Associate Investigator at the Viron Molecular Medicine Institute in Boston, MA, USA and Editor in Chief of the journal Discoveries. He has over a decade of training and research experience at the Harvard Medical School: Postdoctoral Fellow at BIDMC and Harvard Medical School, Instructor in Pathology (Faculty), Harvard Medical School (2017-2018); Associate Member, Wyss Institute of Biologically Inspired Engineering at Harvard (2014-2015), Associate Member of the Ludwig Cancer Center at Harvard University, Boston, MA (2016-2018), affiliated with Broad Institute of MIT and Harvard, Boston, MA (2016-2018). Dr. Octavian Bucur has made impactful contributions in several research fields, being one of the main developers of Expansion Pathology (Nature Biotechnology 2017 (in the top 5% of all research outputs scored by Altmetric), Nature Protocols 2020; 3 patents). This method extends the current resolution limit (250 nm) of the optical microscopes to 70 nm, enabling visualization of smaller nanoscopic structures with inexpensive optical microscopy in preserved tissue specimens, after physical tissue expansion. Expansion-related technologies have tremendous implications in several biomedical fields, including diagnostic pathology, neuroscience and molecular medicine. Among the honors and awards received over the years are: Recognition of Outstanding Achievement in Translational and Basic Science Research from the Harvard Medical School Pathology Department; ranked 1st out of >100 - Best Scientific Poster Award (2017, Harvard Medical School Pathology Retreat of MGH, BIDMC, BWH, DFCI, Children’s Hospital Boston); The American Association for Cancer Research (AACR)-Millennium Pharmaceuticals Award (2015, Philadelphia, PA), IUBMB Travel Fellowship (2010, Melbourne, Australia), The American Association for Cancer Research (AACR)-Aflac Award (2008, San Diego, CA); Lady Tata Memorial Trust International Award for Leukemia Research (2007, London, UK); European Union - Leonardo da Vinci Research Award (2004, Magdeburg, Germany); Invited Keynote Speaker/Special Lectures (conferences in San Francisco, Chicago, London (UK), Bucharest (Romania), BIDMC, Harvard Medical School - Boston, Wayne State University - Detroit, Carol Davila University, Romania); Chair of the Scientific Selection Committee for the RALI's Grand Rounds competition, Research Assistant Learning Initiative, Boston (2017-2018); Invited Judge for many undergraduate/graduate research competitions; International grant evaluator. Dr. Octavian Bucur is a Co-Founder, major stakeholder and was the first CEO of Viron Therapeutics, Boston, MA. He is also leading a prolific research group at the Victor Babes National Institute of Pathology in Bucharest, selecting and training some of the most promising students and young researchers from Romania (nextgenpathology.eu).

Dr. Frank Gupton is a professor at virginia commonwealth university and holds joint appointments in the Departments of Chemistry and the Department of Chemical and Life Science Engineering. He is the Floyd D. Gottwald Chair of Pharmaceutical Engineering and also serves as Department Chair of the Chemical and Life Science Engineering Department. His thirty-year industrial career centered on the development and commercialization of chemical processes for pharmaceutical applications. Dr. Gupton’s research group is currently focused on the development of continuous processing technology to facilitate the discovery, development and commercialization of drug products. Prior to joining the faculty at Virginia Commonwealth University, Dr. Gupton served as the Executive Director of North American Process Development for Boehringer Ingelheim Pharmaceuticals and led the commercialization of the widely prescribed HIV drug nevirapine. Dr. Gupton received his Bachelors of Science degree in chemistry from the University of Richmond and graduate degrees in organic chemistry from Georgia Tech and Virginia Commonwealth University.

Prof. Yaron Ilan, M.D. serves as the Chief Medical Officer at Immuron Limited. Prof. Ilan is a Partner at Jerusalem Technology Investments Ltd. Prof. Ilan serves as a Medical Director of Exalenz Bioscience Ltd. Dr. Ilan has founded several startup companies and serves as Medical Director and Advisor for several biotech companies. Prof. Ilan served as a Medical Director and Consultant at Immuron Limited. He served as Chief Scientist at Exalenz Bioscience Ltd. Prof. Ilan served as the President at the Israel Liver Association from 2005 to 2008. Prof. Ilan serves as a Director of the Department of Medicine at Hebrew University- Hadassah Medical Center. Prof. Ilan serves as a Director of Exalenz Bioscience Ltd. He served as a Member of Scientific Advisory Board at Therapix Biosciences Ltd. until January 6, 2016. Prof. Ilan served as a Director of Exalenz Bioscience Ltd from May 2006 to April 2015. He was Vice Dean at the Hebrew University Medical School. Prof. Ilan is a world-renowned Scientist in the field of internal medicine, immunology and liver diseases. He holds over 40 patents and has authored more than 250 articles. Dr. Ilan is the Inventor of a number of drugs being developed by international pharmaceutical companies. His post-graduate training was acquired at Albert Einstein College of Medicine, Mount Sinai Medical Center and Harvard University. He graduated as well as studied his Doctorate from Hebrew University of Jerusalem.

Dr Cho’s main research interests have been focusing on cancer studies to discover biomarkers for cancer diagnosis, treatment prediction and prognostication. As a seasoned researcher, Dr Cho hasconducted cancer research in using molecular biology, proteomics, genomics, immunology as well as bioinformatics, his current H-index is 67. Dr Cho has published over 500 peer-reviewed papers (Lancet Oncology, Annals of Oncology, Lancet Gastroenterology & Hepatology, Advanced Science, Nature Communications,PNAS,Molecular Cancer,Journal of Thoracic Oncology,Journal of the National Cancer Institute,Journal of Extracellular Vesicles, Clinical Cancer Research, Clinical Chemistry, Theranostics, etc) covering cancer biomarkers, proteomics, non-coding RNAs, Chinese medicine and dozens of books including "An Omics Perspective on Cancer Research", "MicroRNAs in Cancer Translational Research", “Drug Repurposing in Cancer Therapy: Approaches and Applications”and "Supportive Cancer Care with Chinese Medicine" etc. The accumulated impact factors of the journals over 3,000 and these papers have received >20,000 citations.

Dr Akhilesh Sharma is M.D., in Clinical Pharmacology with further training in Clinical Research and Global Pharmacovigilance at Berkley Extension, California State University, USA and Luton Medical Centre, UK and is Fellow of Royal Liverpool hospital society-U.K.. He has around 30 years of worldwide experience in areas of Clinical Research, Medical Affairs, Regulatory, Pharmacovigilance, Translation Medicine, Biomarkers, Clinical Pharmacology across various multinational pharmaceutical companies based at US & in India. He is currently President & Chief Medical Officer for Alkem Laboratories Ltd. He also co-founded biomarker research organization GeneXY in Philadelphia, USA jointly with Wistar institute, Pennsylvania university campus. Been on panel of Clinical Research and Drug Safety at various national and international forums including at USFDA workshops and is an invited faculty at leading international conferences & institutes. Passionate about translational research and innovations in clinical trials. Has to his credit more than 54 scientific & research publications, 52 patents and holds membership of International Pharmaceutical Society, American Academy of Dermatology, American Diabetes Association, European Society of Respiratory Medicine.

Sergey Suchkov was born in the City of Astrakhan, Russia, in a family of dynasty medical doctors. In 1980, graduated from Astrakhan State Medical University with MD. From 1980 through 1983 has been working as Res Associate, and from 1983 through 1985 as Senior Res Associate at the Inst of Medicical Enzymology, USSR Academy of Medical Sciences. In 1985, maintained his PhD at the Sechenov University. From 1986 through 1989, has been working as Senior Res Associ- ate at the Koltzov Institute of Dev Biology, USSR Academy of Sciences. From 1989 through 1994, was a Director of the Division of Clinical Immunology, Helmholtz Eye Res Institute in Moscow. In 1989-1993, was trained at the NEI, NIH, Bethesda, MD, USA, and Wills Eye Hos- pital, Philadelphia, PA, USA, as well as at some of the British universities on the invi- tation of the Royal Society for Immunology. In 1993-1996, was an Executice Secretary-in-Chief of the Editorial Board, Biomedi- cal Science, an int journal published jointly by the USSR Academy of Sciences and the Royal Society of Chemistry, UK. From 1994 through 2006, was a Director (full-time job) of the Division for Clinical Immunology, Vladimiskii Moscow Clinical Research Institute (MONIKI), and The Clinical Immunology Physician-in-Chief (quater-time job) of the Moscow region. In 2002, maintained his Doctor’s Degree at the National Institute of Immunology, Rus- sia. In 1999, was working as a Clinical Immunology Physician (quater-time job) at the “Ehinacea” Clinical Center in Moscow, Russia. From 2006 through 2014, was The First Vice-President (full-time job) of The Univer- sity of World Politics and Law, Moscow, Russia. From 2000 through 2007, was collaborating with some US and European Healthcare and Pharma companies (half-time job) staying in Moscow, Russia. From 2003 through 2021, was a Professor (quator-time job) of the Dept for Clinical Human Pathology of Sechenov University,Moscow, Russia. From 2007 through 2021, is a Professor (quator-time job) of the Dept for Clinical Al- lergology & Immunology of A.I. Evdokimov Moscow State University of Medicine & Dentistry, Moscow, Russia. From 2014 through 2021, was a Professor and Director (full-time job) of the Dept (since 2016 The Center) for Personalized & Precision Medicine of Sechenov Univer- sity,Moscow, Russia. From 2021 through 2021, is a Professor and Chair (full-time job) of the Dept for Per- sonalized Medicine, Precision Nutriology & Biodesign of the Institute for Biotecholo- gy & Global Health of the RosBioTech National University, Russia. From 2004 through the present, utilizing an experience gained whilst staying in USA, Europe and Japan, was doing a lot to implement technologies and philosophy of Per- sonalized and Precision Healthcare services into the daily clinical practice of Russia. Have prepared and finalized a Business Plan for getting it done in a stepwise manner! At present, Dr Sergey Suchkov is: 2 Professor and Chair (full-time job) of the Dept for Personalized Medicine, Preci- sion Nutriology & Biodesign of the Institute for Biotechology & Global Health of the Russian Biotechnology University (RosBioTech), Russia. Professor, Department for Clinical Allergology & Immunology, A.I. Evdokimov Moscow State University of Medicine & Dentistry (MGMSU), Russia Member, EPMA (European Association for Predictive, Preventive and Personal- ized Medicine), Brussels, EU Member, PMC (Personalized Medicine Coalition), Washington, DC, USA Member, ISPM (International Society for Personalized Medicine), Tokyo, Japan Member, American Chemical Society (ACS), Washington, DC, USA Member, New York Academy of Sciences, New York, USA Member, ARVO Foundation of Eye Research, USA Member, ISER (International Society for Eye Research), USA Member, American Heart Association (AHA), Houston, Texas, USA Member, International Association for Medical Education (AMEE), Dundee, UK Secretary General, United Cultural Convention (UCC), Cambridge, UK

Karol Bruzik received his BSc degree (1972) from the Technical University of Lodz, Poland, and his PhD (1980) and DSc (1987) degrees from Polish Academy of Sciences. After postdoctoral work at The Ohio State University (1981-83 and 1990-93) he joined the Department of Medicinal Chemistry and Pharmacognosy at the University of Illinois at Chicago as Assistant Professor, and is now Professor and Associate Head for Curriculum. He is an author of more than 100 peer review publications in the area of organic and bioorganic chemistry, enzyme mechanisms, phosphoinositide signaling and allosteric modulators of ligand-gated ion channels, with emphasis on GABAA receptors.

Prof. Shlomo Yitzchaik received his Ph.D. in chemistry from the Weizmann Institute of Science, Israel, in 1991. Between 1992-1995 he did his post-doc at Northwestern University - USA, in the lab of Prof. Tobin J. Marks. In 1996 he joined the institute of chemistry at the Hebrew University of Jerusalem, Israel. Since 2006 he is a Professor of Chemistry at the Hebrew University. Since 2020 he is the head of the Institute of Chemistry.His major research interests (https://yitzchaik.huji.ac.il/) are biosensors and surface chemistry; he developed developed a modular method to link molecular transducers to various surfaces achieving highly selective and sensitive biosensing devices detecting ions, neurotransmitters, biomolecules, and neuronal activity. More specifically, biosensors for enzymatic activities including kinases and neuraminidases are screened for early diagnosis of lung cancer and autoimmune diseases. Prof. Yitzchaik won the outstanding young scientist prize from the Israeli Chemical Society, the Richard-Willstätteraward from the German Chemical Society, the Applied Materials Research Excellence Prize from the Israel Vacuum Society, the Kaye Innovation award at the Hebrew University, The Braun-Roger-Siegel prize by the Israel Science Foundation,The John van Geuns award by the University of Amsterdam. Currently,he holds the Binjamin H. Birstein Chair in Chemistry.He published more than 140 papers in peer-reviewed journals and holds about 20 patents mostly in the field of biomedical sensors.

Vakhtang Barbakadze has his expertise in isolation and structure elucidation of a new series of plant polyethers, which are endowed with pharmacological properties as immunomodulatory, antioxidant, antiinflammatory, wound-healing and anti-cancer agents. Besides, he interested in enantioselective synthesis and biological activities of basic monomeric moiety of these biopolyethers, synthesis of enantiomerically pure epoxides as chiral building blocks for the production of synthetic analogues of natural polyethers by chemical and enzymetic catalysis. He has received PhD degree in Chemistry and DSci degree in Biology in 1978 and 1999 from Institute of Organic Chemistry, Moscow, Russia and Institute of Biochemistry and Biotechnology, Tbilisi, Georgia, respectively. He is Head of the Department of Plant Biopolymers and Chemical Modification of Natural Compounds at Tbilisi State Medical University I.Kutateladze Institute of Pharmacochemistry. In 1996 and 2002 he has been a visiting scientist at Utrecht University, Departments of Pharmacognosy and Medicinal Chemistry, Utrecht, The Netherlands, by University Scholarship and The Netherlands organization for scientific research (NWO) Scholarship Scientific Program, respectively. He is also an organizing committee member and renowned speaker for many reputed scientific conferences. He has published more than 100 papers in reputed journals. In 2004 he was Georgian State Prize Winner in Science and Technology. 1 Patent P 2012 5391 B (Patents for inventions, NATIONAL INTELLECTUAL PROPERTY CENTER OF GEORGIA SAKPA¬TEN¬TI).

Dr. Ioannidis is currently an Assistant Professor of Surgery in the Medical School of Aristotle University of Thessaloniki. He studied medicine in the Aristotle University of Thessaloniki and graduated at 2005. He received his MSC in “Medical Research Methodology” in 2008 from Aristotle University of Thessaloniki and in “Surgery of Liver, Biliary Tree and Pancreas” from the Democritus University of Thrace in 2016. He received his PhD degree in 2014 from the Aristotle University of Thessaloniki as valedictorian for his thesis “The effect of combined administration of omega-3 and omega-6 fatty acids in ulcerative colitis. Experimental study in rats.” He is a General Surgeon with special interest in laparoscopic surgery and surgical oncology and also in surgical infections, acute care surgery, nutrition and ERAS and vascular access. He has received fellowships for EAES, ESSO, EPC, ESCP and ACS and has published more than 180 articles with more than 3000 citations and an H-index of 28.

Prof Ramesh Gupta is formerPro vice chancellor of Nagaland Central university and Vice Chancellor Radha Govind University,Jharkhand India, had obtained PhD as the age of 23 yearsHe received his Bachelor of Science in Biochemical Science, and Master of Science in organic chemistry, and Doctorate in Chemistry at Lucknow University India, on Drug Development.Dr. Ramesh Gupta is a Medicinal & Bioorganic Chemist andhas worked for several years as visiting professor/Scientist in various Medical schools; Louis pasture University France, University of Arizona USA, Osaka University& Nagoya University Japan, Kyung Hee University, Korea advance institute of science and technology (KAIST) Korea, Ben-Gurion University Israel, Linkoping University Sweden, University of Mons Belgium, University of Western Australia, Sydney ,University of Bergen ,Norway and some others.Prof Guptas’ research focuses on the Natural & Synthetic Drug Development, role of sulfur amino acids in health care, functional food, nutraceuticals and environmental Biotechnology &gender issues.

Prof. Hanna Romanowicz, During the years 2003-2005, I participated in a training session, organised at the International Centre of Inherited Cancers in Szczecin, supervised by Prof. Jan Lubiński. In the course of the training, I learned in detail the organisation of Outpatient Oncological Genetic Clinics, carried out by a team of Prof. Jam Lubiński. That training helped me organise and open the Outpatient Oncological Genetic Clinic at the Institute-Polish Mother’s Memorial Hospital in Lodz, which I then conductedduring the years 2004-2007 and which was met with great interest and appreciation of patients and physicians. On 4/5 December 2015, I participated in an educational meeting: “Learning of tumour biology as the basis for optimisation of diagnostic-therapeutic management”, held in Warsaw. As a pathologist, I was particularly interested in the aspect of HER2 receptor status. In cases with a borderline status of the HER2 receptor, an evaluation by hybridisation in situ is recommended (e.g., FISH, CISH). I implemented the CISH method at the Department of Clinical Pathomorphology of theInstitute-Polish Mother’s Memorial Hospital, therefore, the above-mentioned meeting was a valuable exchange of experiences with other centres, regarding HER2 evaluation.On 8th June 2016, I participated in the conference: “Biobanks: a challenge in the times of Big Data” in Warsaw. It was an international conference, dedicated to the issue of biobanks as an innovative tool for biomedicine development. My participation in that conference extended my knowledge of the legal regulations and recommendation, concerning the use of data by biobanks. A summary of the scientific output Impact Factor – 130 The Hirsch Index - 19

Clelia Dallanoce has received her Master's degree in Pharmaceutical Chemistry and Technology in 1990 and the Master's degree in Pharmacy in 1995 from the University of Milan. After working in Pierrel SPA and in Marion Merrel Dow, in 1996 she has joined the University of Milan becoming assistant professor of Medicinal Chemistry. Since 2018, she is associate professor at the Department of Pharmaceutical Sciences where she coordinates the scientific activities of the IAMC Group (Innovative Approaches in Medicinal Chemistry Group). During the academic career her research lines have focused on the design and synthesis of muscarinic orthosteric and dualsteric molecules, and nicotinic compounds for studying ligand-receptor interactions and activation. Recently she has also directed her research to stable and unstable isotope-labeled ligands for drug discovery and development. She has more than seventy-five papers cited over 1500 times, and her publication H-index is 21. She is co-inventor of 5 patents.

Francesca Gado has received her master degree in Pharmaceutical Chemistry and Technology in 2014 at the Department of Pharmacy, University of Pisa. She completed the PhD at the University of Pisa in 2018 and worked in the same group until the end of 2021. In 2022 she started a new position at the University of Milan as Junior Research Scientist. During the years spent at the University of Pisa her research focused on the synthesis and development of modulators of the cannabinoid receptors more specifically on allosteric and dualsteric ligands. At the University of Milan she started working on the extraction processes of natural matrices, their fractionation and biological evaluation on different cell models. She presented her work in national and international conferences as posters or as oral communications. She has 30 papers with a publication h-index of 10

Laura Fumagalli is currently an Associate Professor at the Department of Pharmaceutical Sciences, University of Milan, Italy. She received her Ph.D. degree in Pharmaceutical Science at university of Milan in 2004 defending a thesis regarding “ Design, Synthesis and Biological Evaluation of ligands targeting alpha-1 adrenergic receptor subtypes. Her research interests focus on medicinal chemistry and chemical biology. Her approach to the medicinal chemistry is based on the traditional cycle “design-synthesis-test-QSAR analysis The chemical biology interest started when she joined as visiting scientist the Professor Tawfik’s group at the Weizmann Institute of Sciences, Israel, in 2014. Her motto in chemical biology is “develop chemistry to understand biology”. Moreover she has discovered a new and promising antimicrobial agent which has been patented by the University of Milan. Beside these main interests she takes up the challenge of resolving and isolating enantiomers of bioactive molecules developing feasible methods. She strongly believes in a sustainable development so she is motivated in developing alternative synthetic methods in order to globally minimize the environmental impact.

Ahmed Hegazi is currently a Professor of Microbiology and Immunology in the National Research Center, Egypt. Prof. Hegazi received his master’s degree in 1979, and his PhD in 1981. Hegazi's research work has been focused lately on bee products and their therapeutic effects. Dr. Hegazi awards; First Class Decoration of Excellence, Egypt, 1995, The Senior Scientist Prize of National Research Center, Cairo, Egypt, 1996, The National Scientific Prize In Biological Sciences, Egypt, 1990, The Scientific Prize of The National Research Center, Cairo, Egypt, 1989, The Second Best Research Paper Award, International Congress of Propolis, Bones Aires, Argentina, 2000, Main Speaker Award,10 th Academic Conference, PRA and NAS (Nippon Apitherapy Soc.) Japan, 2006, 2 Bronze medals from The International Innovation Fair of the Middle East, Kuwait, 2007 Awarded of Ghazi Wad Allah Salon Prize, 2008. Awarded the Merit Aware of Medical Sciences, The National Research Center, 2016. Dr. Hegazi contributed Chairman of the National Committee for Microbiological Sciences (NCMS) in Egypt, Academy of Science and Technology, Egypt, from 2018. Hegazi organized and contributed to national and international research projects since 1977 and up till now; he has been the principal investigator on multiple research projects within the National Research Center. He Conducted training courses on Clinical Microbiology, National Research Center in 1979.

Prof. Beata Smolarz, Genetics and Radiobiology at the Department of Biology and Environment Protection of the University of Lodz. 2015 - the award of the post-doctoral degree in medical sciences - in the field of medicine 17th June 2015 - the post-doctoral degree in medical sciences in the field of medicine 2020 – the position of Professor of the Polish Mother's Memorial Hospital - Research Institute in Lodz. 2021 - professor Training session 2003-2005, training session, organised at the International Centre of Inherited Cancers in Szczecin, Poland. 2010, training, organised at the Department of Molecular Pathology, the Maria Sklodowska-Curie Institute - Oncology Centre in Warsaw. The training concentrated on mastering the FISH technique, particularly useful in the diagnostics of patients with breast cancer. 2013, training session, organised by the StatSoft Polska, and devoted to: “The application of data mining statistics in scientific research”. 2015, training session: Diagnostic Immunohistochemistry for Pathologists, held in Krakow, 12-13 October 2015. 2015, training at the Department of Clinical Pathomorphology, Polish Mother’s Memorial Hospital - Research Institute in Lodz, which concerned mastering the CISH (chromogenic in-situ hybridisation) technique, especially useful in the diagnostics of patients with breast cancer. 2017, application training in virusological tests on the cobas 4800 system. In the area of my scientific interests, there are studies of genes and their polymorphisms, which may participate in the occurrence of human diseases, such as cancer (breast, ovarian or endometrial), endometriosis and neurological diseases (epilepsy). A summary of the scientific output Impact Factor – 120 The Hirsch Index - 19

Dr. Yang-Soo Kim is a seasoned Orthopaedic Surgeon with a career spanning more than three decades. His academic journey began at the Catholic University College of Medicine, where he earned his M.D. Master's and Ph.D. degrees in Orthopaedic Surgery. Following this, he undertook clinical fellowships at the prestigious New York Presbyterian Hospital, Columbia University, specializing in shoulder, elbow, and sports medicine. Professionally, he has advanced through the academic ranks at the Catholic University of Korea, starting as an instructor in 2003, and now serving as a Professor at Seoul St. Mary's Hospital since 2014. His combined expertise in clinical practice and academia distinguishes him as a leading authority in Orthopaedics.

With a background in Physics and a Ph.D. in Medicine, I serve as an Orthopaedic Surgeon at Seoul St. Mary's Hospital, Catholic University of Korea, with a specific focus on shoulder surgery. I bring a distinct analytical approach to my clinical practice, where the principles of physics enrich my understanding of the complex biomechanics of the shoulder. As a Clinical Fellow, my commitment extends beyond surgical procedures to include extensive research, patient care, AI, and the continuous pursuit of advancing my knowledge in the orthopaedic field.

Peng Zhan obtained his B.S. degree from Shandong University, China, in 2005. He then earned his M.S. and Ph.D. degrees in medicinal chemistry from Shandong University in 2008 and 2010. He subsequently joined the research group of Professor Xinyong Liu as a Lecturer (2010−2012). From 2012 to 2014, he worked as a postdoctoral fellow funded by JSPS (Japan Society for the Promotion of Science) in the Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Japan. He is currently a full professor in the Department of Medicinal Chemistry, Shandong University. His research interests involve the discovery of novel anti-viral (HIV, HBV, influenza, coronavirus, etc.), anti-gout, and anti-cancer agents based on rational drug design and combinatorial chemistry approaches.

Dr Ausra Baradoke - a researcher with 10+ years of work experience in 8 scientific groups (including University of Oxford). The PhD was achieved in collaboration with the Center for Physical and Technological Sciences with Irish universities Dublin City University and Trinity College Dublin. Dr. Ausra Baradoke received Innovate UK funding at University of Oxford, where she successfully published 2 high-impact publications and contributed to a patent in the field of electrochemical sensors. Among the scientific achievements, a total of 7 scientific publications in high-impact international scientific journals , patent application, science popularized by presenting research at 27 conferences. She carried out research experimental development (R&D) work in projects funded by the Education Exchange Support Fund, Erasmus +, Innovate UK and Mobilitas Pluss. Also she successfully implemented the "Intellect LT" project (VP2-1.3-uM-02-K-04-122) and contributed to METASENS (CH-3-SMM-01-11), G ‐ SUPERCAP (3200-P325, LAT-16002 ). The PI has work / cooperation experience in private companies in the field of sensor development at ERUMPO LTD and later at Osler Diagnostics LTD. Dr. Ausra Baradoke has been supervising students of various levels (bachelor's, master's, doctoral) in universities: Vilnius University, Dublin City University, Trinity College Dublin, University of Tartu and University of Oxford.

Dr. Maninder Singh is currently working as Brain Pool invited Scientist at Global AI Drug Discovery Center, Ewha Womans University, Seoul, South Korea, where the research projects of their group use AI and CADD methods including modeling of machine learning and deep learning prediction models, virtual screening, molecular modeling, docking, MD simulations. Earlier he did his B.Sc. in Biotechnology from Bundelkhand University, Jhansi, India and M.Sc. in Marine Biotechnology from Goa University, Goa, India. In M.Sc, he worked on Bioremediation of heavy metals. He joined CSIR-CDRI, Lucknow, India for his P.hD, where he learnt CADD and AI methods. He was also involved in the mentoring of participants enrolled in the certificate course in “Computational Approaches to Drug Design and Development”, CSIR-CDRI Skill Development Program, Skill India Initiative, Govt. of India. In later years, he worked with research groups of CSJM University, Kanpur and NIPGR, New Delhi, in projects related to structural biology and Genome-wide studies. In his ongoing learning process, he learnt to process the blood and tissue samples of cancer patients for FISH and Karyotyping in Oncquest Laboratories, New Delhi (BCIL-BITP program) and plant tissue culture in CSIR-IHBT, Palampur, India. Among the awards and fellowships, he received fellowships from DBT, India for his M.Sc, BCIL-BITP and Ph.D program, CDRI-Incentive award for research excellence, Brain Pool fellowship (NRF, South Korea). Apart from that, he likes poetry, drawing, hiking, rock climbing, badminton. His artwork “SARS-CoV2 - An Interactive Infection” is recognized in IBAB Sci-Art 2020, India. Colleagues and friends enjoy his poetry at various events.

Dr. Hsien-YuanLane, have been devoted to clinical and translational research for brain disorders for decades, and have been leading in clinical studies on NMDA receptor (NMDAR)-related biomarkers and enhancer, such as sodium benzoate (the pivotal D-amino acid oxidase [DAAO] inhibitor), for early detection and treatment of schizophrenia and other brain disorders with cognitive dysfunction. I have got encouraging findings; and several papers have been published on first-rate journals, including JAMA Psychiatry, Molecular Psychiatry, Biological Psychiatry, JAMA Network Open, and Psychiatry and clinical neurosciences. I have demonstrated unique ability to bridge basic and clinical research, and to address issues that are of both clinical and theoretical significance. I am poised to help move the field of neuropsychopharmacology forward in the directions that will greatly enhance our understanding of schizophrenia and other brain disorders and our ability to care for patients afflicted with severely brain dysfunction.

My research work mainly focuses on the construction and function of DNA nanomachines, which are cutting edge and challenging topics. I designed and constructed unique DNA molecular tension probes using a short circular DNA nanotechnology technique and functionalized these probes with fluorophores, gold nanoparticles, small molecular drugs, and peptide ligands. I achieved nano-specific precision in organizing plasmonic nanoparticles on the nano DNA frameworks to achieve plasmon resonance effects. My work on the DNA nanomachines provided an efficient mechanism of fluorescence resonance energy transfer that realizes the bio-imaging, and detection of biological events, and functions of the biomolecules. I have been working on multilayered hybrid magnetic nanoparticles for applications in nanomedicine from last two years.

Education and training: Feb. 2003 PhD Degree – from Oregon Health & Science University, Portland, Oregon (USA); Dic. 2003 Clinical Pathology Residency – from Medical School, University "G. D'Annunzio", Chieti (Italy); Nov. 2009 Sciences of Nutrition Residency – from Medical School, University "G. D'Annunzio", Chieti (Italy). From 1st September 2015 she is a Director of Clinical Biochemistry and Emergency Laboratory, Romagna Greater Area , Cesena (Italy). She has published more than 20 papers in reputed journals and has been serving as an editorial board member of repute.

He holds M.Sc., M.Phil., Ph.D. in Microbiology and Certificate in Medical Microbiology from Hygiene – Institute Department of Hygiene and Medical Microbiology, Ruprecht-Karls-University Heidelberg, Germany in collaboration with C. C. S. University. He is working as Faculty in Medical Laboratory Technology, Faculty of Paramedical sciences, Uttar Pradesh University of Medical Sciences, Saifai, India. He has been former Head of the department of Microbiology, Institute of Applied Medicines, and Research, Duhai, DelhiNCR and Combined (PG) Institute of Medical Sciences and Research, Dehradun U.K. His 18 years contribution to teaching and research is supported by 19 international papers, 02 Books and 02 Book chapters. He has supervised more than 25 masters’ students and guided Doctorate students in Microbiology. During this COVID-19 pandemic he has been actively involved for SARS CoV-2 RT-PCR testing at Viral Research and Diagnostics Laboratory (VRDL), Department of Microbiology. He is Editor-in-chief of International Journal of Medical and Allied Health Sciences and also serving as Editor and reviewer for several notable journals in the field of Microbiology, Biotechnology, and Allied Health Sciences. His current research focuses on the design of effective Antimicrobial and Regenerative Medicine therapeutics that can repair, replace, tissues and organs to restore their normal function with implication in Medicine, Pharmacology, Food and Beverage Industry.

Dr. Anju Goyal is currently working as Professor & Head in Department of Pharmaceutical Chemistry at Chitkara College of Pharmacy, Chitkara University, Rajpura, Punjab, India. She received her B.Pharmacy degree from Maharishi Dayanand University, Rohtak in 2002. She has completed her M.Pharmacy and Ph.D. Degree in Pharmaceutical Chemistry from Guru Jambheshwar University of Sciences & Technology, Hisar, Haryana, in 2004 and 2012 respectively. In 2004, she joined the Department of Pharmacy, Jan Nayak Ch. Devi Lal Memorial College of Pharmacy, Jan Nayak Ch. Devi Lal Vidyapeeth, Sirsa, Haryana as a Lecturer, and joined Rajendra Institute of Technology & Sciences, Sirsa, Hryana in 2005 as lecturer. Since July 2009, she has been with the Chitkara College of Pharmacy, Rajpura, where she was an Assistant Professor, became an Associate Professor in 2011, and a Professor in 2015. Her current research interests include Synthesis and Derivatisation of Heterocyclic Compounds to get final Nitric Oxide Donors , Ananytical Method Validation and Derivatisation of Natural Compounds and their Formulations.y. She is a Life Member of the Association of Pharmacy Teachers of India (APTI), Indian Hospital Pharmacist Association (IHPA), Indian Pharmacy Graduates Association (IPGA) and Society of Pharmacovigilance of India (SOPI). She has more than 40 Publications to her credit. She has attended and has also presented papers in National/International Seminars and Conferences. She is the editor of book “Advanced Analytical Techniques Volume-I” by Bentham Publishers and co-author of the book “Pharmaceutical Chemistry-VI (Medicinal Chemistry-1)” published by Thakur Publications and book chapters. She is reviewer and editorial board of reputed national and international journals.

Semenov Institute of Chemical Physics (Russian Academy of Sciences, Moscow), Department of Chemical and Biological Processes Dynamics [FRC CP RAS, CHEMBIO Dept.], Moscow, Kosygina str. 4 Oleg V. Gradov is the Senior Researcher at the Semenov Institute of Chemical Physics (Russian Academy of Sciences, Moscow), working in the Department of Chemical and Biological Processes Dynamics (CHEMBIO). He is the author of ≈ 200 journal papers. His recent grants include: “Development of the novel physical methods for complex biomedical diagnostics based on position-sensitive mapping with the angular resolution at the tissue and cellular levels using analytical labs-on-a-chip” (RFBR 16-32-00914) and “Lab-on-a-chip development for personalized diagnostics” (FASIE 0019125), "Ferroelectric polymers for biomedical engineering" (RFBR 20-12-50344). He is also an ambassador of “ASAPBio”* (Accelerating Science and Publication in Biology, based in Cambridge, USA). Profiles:  https://www.researchgate.net/profile/Oleg-Gradov  https://www.lens.org/lens/profile/475632185/scholar#  https://istina.msu.ru/profile/gradov/  https://www.linkedin.com/in/oleg-v-gradov-67b368199/  https://www.xing.com/profile/Oleg_Gradov/cv  https://www.facebook.com/o.v.gradov/

Mohammed B Alshammari was born in Saudi Arabia in 1987. He received his B.SC. and M. Sc. degrees in Chemistry from King Saud University, Riyadh, KSA in 2007 under supervision of professor Abdullah almajed and professor Hassan Alhazmi. He Worked in Chemistry department in KSU for 9 years as researcher. He received his Ph.D. degree from Cardiff University, UK, in 2013 under supervision of Professor Keith Smith. His research focused in using of organometallic intermediates in organic synthesis. In 2013, He worked as assistant professor in prince Sattam bin Abdulaziz university and promoted to associate professor in 2019. He has published more than 70 International per-reviewed journal publications and 45 conference proceedings in the area of Organic Chemistry and Chemistry. Supervised 2 M.Sc. students. PI of 3 grants from the University, and 1 grant from the SABIC in collaboration with PSAU. His research interest in the areas of organic synthesis of organic compounds and polymers by difrent methadolgy such as lithiation reaction, Matteson homologation and others. In addition, He published number of papers about the biological activite for synthesied compounds.

Dr. Roche‐Lima earned his PhD in Computer Sciences from the University of Manitoba, Canada. He has a broad background applying computer science to complex biological data. He joined the Medical Science Campus, University of Puerto Rico (MSC, UPR), where he worksas an Assistant Professor teaching topics such as data science, bioinformatics and biomedical informatics. His research areas are focused on the application of artificial intelligence and machine learning methods for prediction, analysis and interpretation of biomedical data.He is also the Director of the Integrated Informatics Service core (IIS) and Coordinator of the Research Infrastructure core (RIC) of the Center for Collaborative Research in Health Disparities, which is a federal funded center for minority institutions at MSC, UPR. The goals of these coresare to provide one point of contact to assist researchers with the general aspects of biomedical informatics (i.e. bioinformatics, health informatics and operational informatics) and other related areas (e.g. genomics and proteomics) as they apply to the biomedical science research.Dr. Roche-Lima most recent papers describe using novel supervised learning algorithms for the implementation of informatics applications to sience

Dr. Jinwei Zhang is a Principal Investigator at the University of Exeter Medical School, UK. His laboratory studies ion channels, transporters, and signalling pathways that associated with human diseases, for examples, stroke that regulated by WNK-SPAK/OSR1-KCC2/NKCC1, hypertension that regulated by WNK-SPAK/OSR1-NCC, and concern with elucidating and targeting ion transporters, kinases, protein-protein interactions using genetic mouse models, small molecules, CRISPR/Cas9 gene-editing technologies, and electrophysiology to aid discovery and validation of new potential drug targets. He is internationally recognized for his expertise in cellular chloride homeostasis and cell volume regulation and drug discovery. He has published more than 70 articles in journals including Nature Medicine, Cell Metabolism, Neuron, Nature Communications, EMBO molecular medicine, Science Signalling, Human Molecular Genetics etc. and has achieved more than 2320 citations

Professor 20.01.2023 Dr. Naeem Hasan Khan Faculty of Pharmacy, AIMST University, Ph.D. Doctor of Pharmaceutical Sciences in the discipline of “ Pharmaceutical Chemistry ” from Katholieke Universiteit Leuven (KUL), Leuven, Belgium in Feb., 1988 in the grade of “GREAT DISTINCTION” (the second highest academic grade awarded by the Belgian Universities). M. Pharmacy in the discipline of “Pharmacology” from the University of Punjab, Lahore, Pakistan, in September 1970. B. Pharmacy University of the Punjab, Lahore, Pakistan, in Sept., 1967. F. Sc. Higher Secondary School Certificate examination in the subjects of Pre-Medical group from Govt. College, Lahore, Pakistan, in 1964. Matriculation Secondary School Certificate examination (matriculation) in the subjects of Science group from Govt. Pilot High School, Wahdat Colony, Lahore, Pakistan, in 1962.